Prevention and Control of Seasonal Influenza with Vaccines, 2019-20 | CDC [Internet]. Cdc.gov. 2019 [cited 21 October 2019]. Available from: https://www.cdc.gov/flu/professionals/acip/index.htm
Lankelma J, Hermans M, Hazenberg E, Machen T, Dautzenberg P, Koeijvoets K et al. ) Implementation of point-of-care testing and a temporary influenza ward in a Dutch hospital. Neth. J. Med. 2019;77:109-115.
Roy K, Kandil H, Knight M, Thapa M, Groom K. Respiratory viral point of care testing (POCT) allows improved infection control and bed management during an influenza outbreak. Proceeding of European Respiratory Society International Congress 2018, September 15 to 19, Paris, France.
Irving S, Vandermause M, Shay D, Belongia E: Comparison of Nasal and Nasopharyngeal Swabs for Influenza Detection in Adults. Clin. Med. Res, 2012;10:215-218.
Wang H, Deng J, Tang Y: Profile of the Alere i Influenza A & B assay: a pioneering molecular point-of-care test. Expert Rev Mol Diagn. 2018;18:403-409.
Chapin K, Flores-Cortez E: Performance of the Molecular Alere i Influenza A&B Test Compared to That of the Xpert Flu A/B Assay. J Clin Microbiol. 2014;53:706-709.
Nguyen Van J, Caméléna F, Dahoun M, Pilmis B, Mizrahi A, Lourtet J, Behillil S, Enouf V, Le Monnier A: Prospective evaluation of the Alere i Influenza A&B nucleic acid amplification versus Xpert Flu/RSV. Diagn Microbiol Infect Dis, 2016;85:19-22.
Jokela P, Vuorinen T, Waris 2, Manninen R: Performance of the Alere i influenza A&B assay and mariPOC test for the rapid detection of influenza A and B viruses. J Clin Virol. 2015;70:72-76.
Blackmore T, Taylor J, Kelly M, Buckley J, Corban K, Tan C, Balm M: Point of care influenza testing using Alere-i Influenza A & B assay: a practical assessment. bioRxiv. 2018; doi: http://dx.doi.org/10.1101/375493.
Hazelton B, Gray T, Ho J, Ratnamohan V, Dwyer D, Kok J: Detection of influenza A and B with the Alere i Influenza A & B: a novel isothermal nucleic acid amplification assay. Influenza Other Respir Viruses. 2015; 9, 151–154.
Chiarella F, Culebras E, Picazo J, Fuentes-Ferrer M: Evaluation of the Alere i Influenza A&B assay for rapid identification of influenza A and influenza B viruses. J. Med. Microbiol. 2016;65:456-461.
Nie S, Roth R, Stiles J, Mikhlina A, Lu X, Tang Y-W, Babady N: Evaluation of Alere i influenza A&B for rapid detection of influenza viruses A and B. J Clin Microbiol.2014; 52, 3339–3344.
Bell J, Selvarangana R: Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Test by Use of Respiratory Specimens Collected in Viral Transport Medium. J Clin Microbiol. 2014;52:3992–3995
Nolte F, Gauld L, Barrett S: Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid Detection of Influenza Virus Infection. J. Clin. Microbiol. 2016;54:2763-2766.
Young S, Illescas P, Nicasio J, Sickler JJ: Diagnostic accuracy of the real-time PCR cobasLiat Influenza A/B assay and the Alere i Influenza A&B NEAR isothermal nucleic acid amplification assay for the detection of influenza using adult nasopharyngeal specimens. J Clin Virol. 2017;94:86–90.
Bell J, Bonner A, Cohen D, Birkhahn R, Yogev R, Triner W, Cohen J, Palavecino E, Selvarangan R: Multicenter Clinical Evaluation of the Novel Alere™ i Influenza A&B Isothermal Nucleic Acid Amplification Test. J Clin Virol. 2014;61:81–86.
COVID-19 (2019-nCoV) Risk assessment for use in a receiving Hospital setting. Accessed from https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/algorithms/COVID-19%20Risk%20Assessment%20Hospital%20Setting%20v4.0.pdf. Date accessed 19/02/2020
ATC/DDD Index, WHO Collaborating Centre for Drug Statistics Methodology, available at https://www.whocc.no/ Last accessed 03/07/2019.
Hospital Antimicrobial Consumption Surveillance Report, Health Services Executive, 2018
Available at https://www.hpsc.ie/az/microbiologyantimicrobialresistance/europeansurveillanceofantimicrobialconsumptionesac/PublicMicroB/SACHC/SACHC_Current.pdf. Last accessed 15/08/2109
Bell J, Bonner A, Cohen D, Birkhahn R, Yogev R, Triner W, Cohen J, Palavecino E, Selvarangan R: Multicenter Clinical Evaluation of the Novel Alere™ i Influenza A&B Isothermal Nucleic Acid Amplification Test. J Clin Virol. 2014;61:81–86.
Chen J, Lam H, Yip C, Cheng V, Chan J, Leung T, Sridhar S, Chan K, Tang B, Yuen K: Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses. Diagn Microbiol Infect Dis. 2018; 90,177-180.
Why influenza vaccination is important for health care workers (HCWs), HSE National Immunisation Office September 2019 accessed from https://www.hse.ie/eng/health/immunisation/hcpinfo/fluinfo/whyfluhcws.pdf
Accessed from https://www.hpsc.ie/a-z/respiratory/influenza/seasonalinfluenza/influenzaandadults65yearsandolder/Seasonal%20Influenza%20Vaccine%20Uptake_65%20report_Sep-Dec%2018.pdf]
Dellit T, Owens R, McGowan J, Gerding G, Weinstein R, et al.: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clin Infect Dis. 2007;44:159–77.